Orchestra BioMed Holdings, Inc. (OBIO)

Every figure this model derived for OBIO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 781,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 109,963,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 111,241,000 AssetsCurrent 2026-06-30
current liabilities 13,471,000 LiabilitiesCurrent 2026-06-30
equity 19,323,000 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2026-06-30
interest expense 1,445,000 InterestPaid 2026-06-30
ocf -58,320,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 31,976,000 Revenues 2026-06-30
sbc 11,119,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up OBIO on one particular measure came for.

RatioValue
cash operating margin-145.49
current ratio12.61
current ratio reported8.26
deferred revenue growth14.34
dilution pct29.7
fcf margin-184.83
growth cv1.46
interest cover-40.13
operating margin-181.36
owner earnings margin-219.6
revenue growth986.14
revenue growth per share737.45
rpo growth-26.17
rule of 40804.78
sbc pct revenue34.77

What to be careful about

What this model itself distrusts about OBIO's figures. Written by the derivation as it ran, not added afterwards.